These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 32298597)

  • 1.
    Trujillo-Paolillo A; Salinas-Souza C; Dias-Oliveira I; Petrilli AS; Toledo SRC
    J Adolesc Young Adult Oncol; 2020 Dec; 9(6):621-627. PubMed ID: 32298597
    [No Abstract]   [Full Text] [Related]  

  • 2. CYP genes in osteosarcoma: Their role in tumorigenesis, pulmonary metastatic microenvironment and treatment response.
    Trujillo-Paolillo A; Tesser-Gamba F; Petrilli AS; de Seixas Alves MT; Garcia Filho RJ; de Oliveira R; de Toledo SRC
    Oncotarget; 2017 Jun; 8(24):38530-38540. PubMed ID: 28404946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of GRM4 gene polymorphisms with susceptibility and clinicopathological characteristics of osteosarcoma in Guangxi Chinese population.
    Wang K; Zhao J; He M; Fowdur M; Jiang T; Luo S
    Tumour Biol; 2016 Jan; 37(1):1105-12. PubMed ID: 26276359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.
    Caronia D; Patiño-García A; Milne RL; Zalacain-Díez M; Pita G; Alonso MR; Moreno LT; Sierrasesumaga-Ariznabarreta L; Benítez J; González-Neira A
    Pharmacogenomics J; 2009 Oct; 9(5):347-53. PubMed ID: 19434073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of CYP2D6*10, CYP3A5*3, CYP1A2*1F, and ABCB1 C3435T polymorphisms on the pharmacokinetics of flecainide in healthy Chinese subjects.
    Hu M; Yang YL; Fok BS; Chan SW; Chu TT; Poon EW; Yin OQ; Lee VH; Tomlinson B
    Drug Metabol Drug Interact; 2012 Jan; 27(1):33-9. PubMed ID: 22718623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Candidate germline polymorphisms of genes belonging to the pathways of four drugs used in osteosarcoma standard chemotherapy associated with risk, survival and toxicity in non-metastatic high-grade osteosarcoma.
    Hattinger CM; Biason P; Iacoboni E; Gagno S; Fanelli M; Tavanti E; Vella S; Ferrari S; Roli A; Roncato R; Giodini L; Scotlandi K; Picci P; Toffoli G; Serra M
    Oncotarget; 2016 Sep; 7(38):61970-61987. PubMed ID: 27566557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of ERCC1 and ERCC2 gene polymorphysims on response to cisplatin based therapy in osteosarcoma patients.
    Obiedat H; Alrabadi N; Sultan E; Al Shatti M; Zihlif M
    BMC Med Genet; 2018 Jul; 19(1):112. PubMed ID: 29980176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenetics of acenocoumarol: CYP2C9, CYP2C19, CYP1A2, CYP3A4, CYP3A5 and ABCB1 gene polymorphisms and dose requirements.
    Saraeva RB; Paskaleva ID; Doncheva E; Eap CB; Ganev VS
    J Clin Pharm Ther; 2007 Dec; 32(6):641-9. PubMed ID: 18021343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of the folate pathway and transporter polymorphisms on methotrexate treatment outcome in osteosarcoma.
    Goričar K; Kovač V; Jazbec J; Zakotnik B; Lamovec J; Dolžan V
    Pharmacogenet Genomics; 2014 Oct; 24(10):514-21. PubMed ID: 25098908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic polymorphisms in nucleotide excision repair pathway influences response to chemotherapy and overall survival in osteosarcoma.
    Sun Y; Wu Y; Li W; Kong Z; Zou X
    Int J Clin Exp Pathol; 2015; 8(7):7905-12. PubMed ID: 26339355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic polymorphism of CYP1A2 and the toxicity of leflunomide treatment in rheumatoid arthritis patients.
    Bohanec Grabar P; Rozman B; Tomsic M; Suput D; Logar D; Dolzan V
    Eur J Clin Pharmacol; 2008 Sep; 64(9):871-6. PubMed ID: 18496682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin 10 gene -1082A/G polymorphism is associated with osteosarcoma risk and poor outcomes in the Chinese population.
    Cui Y; Zhu JJ; Ma CB; Cui K; Wang F; Ni SH; Zhang ZY
    Tumour Biol; 2016 Apr; 37(4):4517-22. PubMed ID: 26503210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergism between oral estrogen therapy and cytochrome P450 3A5*1 allele on the risk of venous thromboembolism among postmenopausal women.
    Canonico M; Bouaziz E; Carcaillon L; Verstuyft C; Guiochon-Mantel A; Becquemont L; Scarabin PY;
    J Clin Endocrinol Metab; 2008 Aug; 93(8):3082-7. PubMed ID: 18628519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation on the DNA repaired gene polymorphisms and response to chemotherapy and overall survival of osteosarcoma.
    Ji WP; He NB
    Int J Clin Exp Pathol; 2015; 8(1):894-9. PubMed ID: 25755792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlations of CYP2C9*3/CYP2D6*10/CYP3A5*3 gene polymorphisms with efficacy of etanercept treatment for patients with ankylosing spondylitis: A case-control study.
    Chen YY
    Medicine (Baltimore); 2017 Mar; 96(9):e5993. PubMed ID: 28248857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development of the high resolution melting method for genotyping CYP2C9*3 (1075A/C, rs1057910) and VKORC1 (-1639A/G, rs9923231)].
    Cui GL; Ding H; Xu YJ; Chen C; Wang DW
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Jun; 40(6):477-81. PubMed ID: 22943641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic metabolism and transporter gene variants enhance response to rosuvastatin in patients with acute myocardial infarction: the GEOSTAT-1 Study.
    Bailey KM; Romaine SP; Jackson BM; Farrin AJ; Efthymiou M; Barth JH; Copeland J; McCormack T; Whitehead A; Flather MD; Samani NJ; Nixon J; Hall AS; Balmforth AJ;
    Circ Cardiovasc Genet; 2010 Jun; 3(3):276-85. PubMed ID: 20207952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of
    Muñoz A; López-Samanes Á; Aguilar-Navarro M; Varillas-Delgado D; Rivilla-García J; Moreno-Pérez V; Del Coso J
    Genes (Basel); 2020 Aug; 11(8):. PubMed ID: 32823594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translesion polymerase genes polymorphisms and haplotypes influence survival of osteosarcoma patients.
    Goričar K; Kovač V; Jazbec J; Zakotnik B; Lamovec J; Dolžan V
    OMICS; 2015 Mar; 19(3):180-5. PubMed ID: 25748439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the MTHFR C677T polymorphism in methotrexate-induced toxicity in pediatric osteosarcoma patients.
    Lambrecht L; Sleurs C; Labarque V; Dhooge C; Laenen A; Sinnaeve F; Renard M; Uyttebroeck A
    Pharmacogenomics; 2017 Jun; 18(8):787-795. PubMed ID: 28592186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.